Entrada Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Entrada Therapeutics, Inc.
CIK #0001689375
EDGAR Form CIK 2011 - 2025
10-K [0001689375]
10-Q [0001689375]
3 [0001689375]
4 [0001689375]
8-K [0001689375]
D [0001689375]
SC 13D [0001689375]
SC 13G [0001689375]
Form 13D/13G Filer Form 13D/13G Subject Filed
Janus Henderson Group PLC Entrada Therapeutics Inc [2025-02-14]
BlackRock Inc Entrada Therapeutics Inc [2025-02-04]
Roche Finance Ltd Entrada Therapeutics Inc [2022-02-14]
Redmile Group LLC Entrada Therapeutics Inc [2022-02-14]
Price T Rowe Associates Inc /MD/ Entrada Therapeutics Inc [2022-02-14]
MRL Ventures Fund LLC Entrada Therapeutics Inc [2022-02-08]
Wellington Management Group LLP Entrada Therapeutics Inc [2022-02-04]
Baker Bros Advisors LP Entrada Therapeutics Inc [2021-12-16]
5AM Ventures V LP Entrada Therapeutics Inc [2021-11-12]
MPM BioVentures 2014 LP Entrada Therapeutics Inc [2021-11-12]
View All
Form 3/4/5 Subject 2011 - 2025
Entrada Therapeutics, Inc.
Parmar Kush
5AM Opportunities I, L.P.
5AM Partners V, LLC
5AM Ventures V, L.P.
Rocklage Scott M
5AM Opportunities I (GP), LLC
Schwab Andrew J.
Kim Peter S
Zeiher Bernhardt G
View All
Terms | Privacy | Guide
tony@aum13f.com